Artificial Intelligence

Navigating the Biotech Winter: Strategies for Survival and Growth Amid Ongoing Industry Downturn

1 week ago talkbio0Tagged Acquisitions, adaptation, Artificial Intelligence, biotech downturn, growth opportunities, innovation, Landscapes, layoff, Precision Medicine, regulatory, strategic, Survival, trends qualifier

biotech downturn, layoff trends, funding challenges, strategic adaptation, innovation, mergers & acquisitions, workforce planning, precision medicine, artificial intelligence, regulatory landscape, survival strategies, growth opportunities

Illumina and Tempus look beyond cancer in new AI-driven genomics deal

1 week ago talkbio0Tagged Artificial Intelligence, Cardiology discipline, Genetic Profile, Genomics, High-Throughput Nucleotide Sequencing, Illumina, Immunology, Malignant Neoplasms, Market, Neurology speciality, Partnership

Illumina, Genomics, Partnership, High-Throughput Nucleotide Sequencing, Malignant Neoplasms, Artificial Intelligence, Cardiology discipline, Neurology speciality, Immunology, Genetic Profile, Artificial Intelligence, Market

PRISM BioLab and Elix Collaborate to Revolutionize AI-Driven Drug Discovery with Peptide Mimetics

1 week ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Drug Discovery, Efficiency, Elix, mimetics, PepMetics, Peptides, pharmaceutical innovation, PRISM BioLab, Protein-Protein Interaction, small molecule inhibitors

PRISM BioLab , Elix , AI drug discovery , Peptide mimetics , Protein-protein interactions , PepMetics® , Small molecule inhibitors , Drug discovery efficiency , Pharmaceutical innovation

Galatea Bio’s $25M Funding Boost for Global Biobank and AI-Driven Genomic Research

4 weeks ago talkbio0Tagged AI-enabled, Artificial Intelligence, Galatea Bio, genomic analysis, Global Biobank, non-European ancestry, Precision Medicine, Variation (Genetics)

Galatea Bio, global biobank, AI-enabled genomic analysis, precision medicine, non-European ancestry, genetic diversity

AI-Powered Drug Discovery Breakthrough: Charles River and Valo Health Identify Lupus Candidate

4 weeks ago talkbio0Tagged Artificial Intelligence, Charles, Drug Discovery, Flagship, Logica, Lupus treatment, Pioneering, Pioneering Medicines, River Laboratories, Valo Health

Charles River Laboratories, Valo Health, Logica platform, AI-driven drug discovery, lupus treatment, Pioneering Medicines, Flagship Pioneering

Six Payer Trends Shaping Market Access in 2025

1 month ago talkbio0Tagged 2025, Access, Artificial Intelligence, Enrollment, Market, payer, payers, Shapes, trends qualifier

Market, trends qualifier, Access, Enrollment, 2025, payer, Shapes, payers, Artificial Intelligence

MeiraGTx and Hologen AI Form $430M Collaboration to Advance Parkinson’s Gene Therapy

1 month ago talkbio0Tagged Artificial Intelligence, Biotechnology, Clinical Trials, gene therapy, Parkinson 's disease

gene therapy, Parkinson’s disease, artificial intelligence, clinical trials, biotechnology partnership

Oncology Market in 2025: Innovation, Growth, and Patient-Centric Care

2 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Biosimilars, Clinical Trial Design, Combined, Immunotherapy for cancer, Neoplasms, Personalized cancer care, Precision Medicine, targeted therapies

Cancer immunotherapy, Targeted therapies , Precision medicine, AI in oncology, Combination treatments, Biosimilars, Clinical trial design, Personalized cancer care